Commonwealth Equity Services
NWBO

Commonwealth Equity Services’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Commonwealth Equity Services’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-45,325
Closed -$25K – 2426
2016
Q3 		$25K Buy
45,325
+300
+0.7% +$137 ﹤0.01% 2208
2016
Q2 		$26K Hold
45,025
– – ﹤0.01% 2190
2016
Q1 		$66K Buy
+45,025
New +$88.8K ﹤0.01% 2109

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Commonwealth Equity Services's NWBO Position: Q4 2016 in Review

Commonwealth Equity Services sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 45,325 shares — an estimated $25K sold.

Commonwealth Equity Services first reported a position in NWBO in Q1 2016 and held it in 3 quarters. The position peaked at $66K in Q1 2016. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Commonwealth Equity Services reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Commonwealth Equity Services sold 45,325 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $25K.
  • Commonwealth Equity Services first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2016 and held it in 3 quarters.
  • Commonwealth Equity Services's Northwest Biotherapeutics, Inc. Common stock position peaked at $66K in Q1 2016.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Commonwealth Equity Services's 13F filing for Q4 2016, filed 1 Feb 2017.